CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Lung Cancer Awareness Month: 2021 Immunotherapy Research Updates

    This November for Lung Cancer Awareness Month, discover the latest treatments, research insights, and our impact on…

    November 1, 2021| Gabriella Rojas
  • Judy Gray

    Judy Gray’s Immunotherapy Story

    Lung Cancer |  Diagnosed 2011 It turned out that my immune cells were just very busy, like little…
    April 27, 2021| CRI Staff
  • Don H.

    Don H’s Immunotherapy Story

    Lung Cancer |  Diagnosed 2013 You’re not a guinea pig. You’re actually getting the first exposure to what…
    April 27, 2021| CRI Staff
  • CRI ImmunoAdvocate Perspective: Lung Cancer Survivor Oswald Shares His Immunotherapy Experience

    CRI ImmunoAdvocate Oswald Peterson discusses his experience receiving a PD-1 checkpoint inhibitor for stage 4 non-small cell…

    January 5, 2021| Caroline Offit
  • Lung Cancer Awareness Month: 2020 Immunotherapy Research Updates

    This November for Lung Cancer Awareness Month, we look at the rapidly changing treatment landscape, adapting cancer…

    November 5, 2020| CRI Staff
  • Dr. Leena Gandhi Answers Questions About Immunotherapy for Lung Cancer from the 2020 CRI Virtual Immunotherapy Patient Summit

    Dr. Leena Gandhi, of Dana-Farber Cancer Institute, answers questions about immunotherapy for lung cancer from the 2020…

    November 2, 2020| CRI Staff
  • How COVID-19 is Impacting Care for Lung Cancer Patients

    CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…

    May 7, 2020| Arthur N. Brodsky, PhD
  • AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome

    The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…

    April 28, 2020| Arthur N. Brodsky, PhD
  • Lung Cancer Awareness Month: 2019 Immunotherapy Research Update

    We round up the latest news and research from the people changing the future of lung cancer…

    November 7, 2019| CRI Staff
1 2 3 4
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute